OncoImmune is a clinical-stage biopharmaceutical company, engages in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease.

Research Grants 26 show all


$195.4K
2015

$1M
2017

$1.4M
2018

$1.5M
2019

$485.4K
2020

Patents 88show all

  • 7
    A61K - Preparations for medical, dental, or toilet purposes
  • 4
    C07K - Peptides

Clinical Trials 6show all

2Phase 12Phase 21Phase 1/Phase 21Phase 3

Contact Information

12111 Parklawn Drive Suite 107
Rockville, MD 20852
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$15,000,0001-102017-01-12Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2017-01-12$15,000,000Series A3E Bioventures